Bio-Based Metal-Organic Frameworks: Synthesis, Structural Engineering, And Applications In Sustainable Catalysis And Biomedicine

Molecular Composition And Structural Characteristics Of Bio-Based Metal-Organic Frameworks

Bio-based metal-organic frameworks are hybrid coordination polymers assembled through the self-organization of metal ions or clusters (secondary building units, SBUs) and multidentate organic ligands sourced from biological or renewable feedstocks 12. The defining feature of bio-based MOFs lies in their use of non-toxic, biocompatible precursors—a critical departure from traditional MOFs that frequently incorporate hazardous solvents and heavy metals 49.

The structural diversity of bio-based MOFs arises from three key design parameters:

• Metal Ion Selection: Biocompatible metals such as Zn²⁺, Fe³⁺, Ca²⁺, and Mg²⁺ serve as coordination centers, forming clusters (e.g., Zn₄O tetrahedra in MOF-5 analogs) that anchor the framework 27. Iron- and aluminum-based SBUs are particularly attractive due to their earth-abundance and low toxicity 516.
• Organic Linker Chemistry: Biomolecules including amino acids (e.g., L-aspartate, L-histidine), cyclodextrins (α-, β-, γ-CD), and naturally derived dicarboxylates (e.g., fumarate, succinate) replace synthetic terephthalates 4911. These linkers introduce functional groups (–OH, –NH₂, –COOH) that enhance hydrophilicity and enable post-synthetic modification 6.
• Framework Topology: Depending on reaction conditions (temperature, pH, solvent polarity, metal-to-ligand ratio), bio-based MOFs adopt 1D, 2D, or 3D architectures 29. Three-dimensional frameworks exhibit interconnected pore networks with pore diameters ranging from 0.5 to 5 nm, facilitating guest molecule encapsulation 12.

A representative example is the cyclodextrin-based MOF (CD-MOF), synthesized by coordinating γ-cyclodextrin with alkali metal ions (K⁺, Na⁺) under aqueous conditions at 60–80°C 11. The resulting framework displays a cubic topology with pore volumes of ~0.6 cm³/g and demonstrates water solubility—a unique property enabling biomedical applications 11. Structural characterization via powder X-ray diffraction (PXRD) confirms crystallinity, while N₂ adsorption isotherms (77 K) reveal BET surface areas of 1200–2500 m²/g for optimized bio-based MOFs 24.

The coordination geometry is typically octahedral or tetrahedral, with metal-oxygen bond lengths of 1.9–2.1 Å (for Zn–O) and 2.0–2.2 Å (for Fe–O), as determined by single-crystal X-ray diffraction 15. Thermogravimetric analysis (TGA) indicates thermal stability up to 250–350°C for most bio-based MOFs, with decomposition onset temperatures dependent on linker rigidity and metal-ligand bond strength 216.

Precursors And Synthesis Routes For Bio-Based Metal-Organic Frameworks

Selection Of Biocompatible Metal Ions And Organic Linkers

The synthesis of bio-based MOFs prioritizes GRAS (Generally Recognized As Safe) metal salts and organic acids to ensure biocompatibility 49. Common metal precursors include:

• Zinc acetate (Zn(CH₃COO)₂·2H₂O) and zinc nitrate (Zn(NO₃)₂·6H₂O) for Zn-based frameworks 212
• Iron(III) chloride (FeCl₃·6H₂O) and iron(III) nitrate for Fe-MOFs with photocatalytic activity 51617
• Calcium chloride (CaCl₂) and magnesium sulfate (MgSO₄) for alkaline earth metal frameworks 79

Organic linkers are derived from renewable biomass or biosynthetic pathways. Examples include:

• Amino Acids: L-aspartic acid, L-glutamic acid, and adenine provide zwitterionic coordination sites 49
• Cyclodextrins: α-CD (6 glucose units), β-CD (7 units), and γ-CD (8 units) offer hydrophobic cavities for guest encapsulation 11
• Biogenic Carboxylates: Fumaric acid (C₄H₄O₄), succinic acid, and citric acid serve as short-chain dicarboxylate linkers 49

Solvothermal And Electrochemical Synthesis Methods

Two primary synthetic routes dominate bio-based MOF preparation:

Solvothermal Synthesis: Metal salts and organic linkers are dissolved in aqueous or mixed aqueous-ethanol solvents (typical ratios: 1:1 to 3:1 water:ethanol) and heated in a sealed autoclave at 80–180°C for 12–72 hours 29. For instance, a Zn-adenine MOF is synthesized by combining Zn(NO₃)₂·6H₂O (0.5 mmol) and adenine (1.0 mmol) in 10 mL H₂O at 120°C for 24 hours, yielding rod-shaped crystals with 85% yield 2. pH adjustment (typically pH 5–8 using NaOH or HCl) is critical to control deprotonation of carboxylate groups and prevent metal hydroxide precipitation 9.

Electrochemical Synthesis: This method employs anodic oxidation of metal electrodes in the presence of organic linkers, offering rapid synthesis (minutes to hours) and solvent-free conditions 1012. For example, a zinc-pyrrole MOF is prepared by oxidizing a zinc anode (99.9% purity) at 10–20 V in a dimethylformamide (DMF) solution containing 2,5-di(4-pyridyl)pyrrole (0.1 M) at room temperature for 2 hours 12. The electrochemical route minimizes thermal degradation of sensitive biomolecules and enables continuous production 10.

Post-Synthetic Modification And Functionalization

Bio-based MOFs can be functionalized via:

• Ligand Exchange: Partial replacement of native linkers with functionalized analogs (e.g., introducing –NH₂ or –SH groups) to enhance catalytic activity 6
• Metal Ion Doping: Incorporation of secondary metals (e.g., Cu²⁺, Co²⁺) into Zn-based frameworks to create bimetallic MOFs with tunable redox properties 68
• Biomolecule Encapsulation: Enzymes (e.g., catalase, glucose oxidase) or therapeutic proteins are entrapped during synthesis by adding them to the precursor solution, resulting in bio-MOF composites with retained enzymatic activity (>70% of native activity) 12

Physical And Chemical Properties Of Bio-Based Metal-Organic Frameworks

Porosity And Surface Area Characteristics

Bio-based MOFs exhibit hierarchical porosity with micropores (<2 nm) and mesopores (2–50 nm) 24. Nitrogen adsorption-desorption isotherms at 77 K reveal Type I or Type IV behavior, indicative of microporous or mesoporous structures, respectively 2. Representative surface area values include:

• Zn-adenine MOF: 1850 m²/g (BET method), pore volume 0.72 cm³/g 2
• γ-Cyclodextrin-K⁺ MOF: 1200 m²/g, pore diameter 1.7 nm (BJH method) 11
• Fe-fumarate MOF (MIL-88B analog): 1500 m²/g, with breathing behavior (pore expansion from 1.0 to 1.6 nm upon guest adsorption) 516

Pore size distribution, calculated via density functional theory (DFT) models, shows narrow distributions centered at 0.8–2.5 nm for most bio-based MOFs, suitable for selective molecular sieving 24.

Thermal And Chemical Stability

Thermal stability is assessed by TGA under N₂ atmosphere (heating rate: 10°C/min). Bio-based MOFs typically exhibit:

• Dehydration: Loss of coordinated water molecules at 80–150°C (5–10 wt%) 29
• Framework Decomposition: Onset at 250–400°C, with higher stability observed for frameworks incorporating rigid aromatic linkers (e.g., adenine-based MOFs stable to 380°C) 2 versus aliphatic linkers (e.g., succinate-based MOFs decomposing at 280°C) 9

Chemical stability in aqueous media is critical for biomedical applications. Cyclodextrin-based MOFs demonstrate complete dissolution in water within 24 hours at pH 7.4 and 37°C, enabling controlled drug release 11. In contrast, Fe-carboxylate MOFs (e.g., MIL-88) maintain structural integrity in phosphate-buffered saline (PBS, pH 7.4) for >7 days, with <5% metal ion leaching 516.

Biocompatibility And Toxicity Profiles

Cytotoxicity assays (MTT, CCK-8) on mammalian cell lines (e.g., HeLa, HEK293) reveal that bio-based MOFs exhibit IC₅₀ values >200 μg/mL, significantly higher than conventional MOFs (IC₅₀ ~50 μg/mL for Cu-BTC) 49. In vivo studies in mice (intravenous injection, 10 mg/kg) show no acute toxicity, with histopathological examination of liver and kidney tissues revealing no abnormalities after 14 days 9. Biodegradation studies demonstrate that cyclodextrin-MOFs are metabolized via enzymatic hydrolysis (α-amylase) within 48 hours, with metal ions excreted renally 11.

Applications Of Bio-Based Metal-Organic Frameworks In Drug Delivery And Therapeutics

Controlled Release Systems For Anticancer Drugs

Bio-based MOFs serve as nanocarriers for chemotherapeutic agents, leveraging their high drug-loading capacity (up to 40 wt%) and pH-responsive release profiles 91519. For example, a Zn-adenine MOF loaded with doxorubicin (DOX) achieves 35 wt% loading via soaking in DOX solution (1 mg/mL in PBS) for 24 hours at 25°C 2. Release kinetics in simulated tumor microenvironment (pH 5.5, 37°C) show 80% DOX release within 48 hours, compared to <20% at physiological pH 7.4, attributed to protonation-induced framework disassembly 29.

A biopolymer-conjugated MOF system combines hyaluronic acid (HA) with Fe-based MOF nanoparticles (50–100 nm diameter) for targeted delivery to CD44-overexpressing cancer cells 15. In vitro studies on HCT116 colon cancer cells demonstrate 3-fold higher cellular uptake of HA-MOF-DOX compared to free DOX, with IC₅₀ reduced from 5.2 to 1.8 μM 15. Photodynamic therapy (PDT) is enabled by loading photosensitizers (e.g., protoporphyrin IX) into the MOF, generating reactive oxygen species (ROS) upon 630 nm laser irradiation (0.5 W/cm², 10 min), achieving 90% cell death 15.

Enzyme Immobilization For Biocatalysis

Encapsulation of enzymes within bio-based MOFs during synthesis (biomimetic mineralization) preserves enzymatic activity while enhancing stability 12. Catalase immobilized in Zn-imidazolate MOF (ZIF-8 analog) retains 75% activity after 30 days at 4°C, compared to 30% for free enzyme 1. The MOF shell (thickness ~20 nm) protects the enzyme from proteolytic degradation and thermal denaturation, with activity maintained at 60°C for 6 hours (free enzyme loses 90% activity under identical conditions) 1.

Glucose oxidase (GOx) encapsulated in cyclodextrin-MOF exhibits size-selective catalysis: glucose (molecular diameter 0.9 nm) diffuses through MOF pores (1.7 nm) to reach GOx, while larger substrates (e.g., sucrose, 1.5 nm) are excluded 11. Kinetic studies yield Km = 8.2 mM and Vmax = 120 μmol/min/mg for GOx@CD-MOF, comparable to free enzyme (Km = 7.5 mM) 11.

Tissue Engineering Scaffolds And Regenerative Medicine

Three-dimensional bio-based MOF scaffolds fabricated via freeze-casting or 3D printing support cell adhesion and proliferation 9. A Mg-fumarate MOF scaffold (porosity 70%, pore size 100–300 μm) seeded with human mesenchymal stem cells (hMSCs) shows 85% cell viability after 7 days in culture, with osteogenic differentiation confirmed by alkaline phosphatase (ALP) activity (2.5-fold increase vs. control) 79. The scaffold degrades gradually over 8 weeks in simulated body fluid (SBF), releasing Mg²⁺ ions that promote bone mineralization 7.

Applications Of Bio-Based Metal-Organic Frameworks In Environmental Catalysis And Gas Storage

Photocatalytic Degradation Of Organic Pollutants

Fe- and Bi-based bio-based MOFs exhibit visible-light photocatalytic activity for wastewater treatment 317. A Bi-Ti bimetallic MOF synthesized from bismuth nitrate, titanium isopropoxide, and terephthalic acid (molar ratio 1:1:2, solvothermal at 150°C for 24 hours) demonstrates a bandgap of 2.1 eV, enabling absorption of λ > 590 nm 17. Under simulated sunlight (100 mW/cm², AM 1.5G), this MOF degrades 92% of methylene blue (10 mg/L, 50 mL) within 120 minutes, with pseudo-first-order rate constant k = 0.025 min⁻¹ 17. Radical trapping experiments identify superoxide (O₂⁻) and hydroxyl (•OH) radicals as primary reactive species 17.

An Fe-fumarate MOF applied to unsymmetrical dimethylhydrazine (UDMH) wastewater treatment achieves 78% chemical oxygen demand (COD) reduction after 4 hours of UV-A irradiation (365 nm, 20 W), with UDMH concentration decreasing from 500 mg/L to <50 mg/L 3. The MOF is integrated into a bio-trickling filter, where immobilized bacteria (Pseudomonas sp.) further mineralize degradation intermediates, achieving total nitrogen removal of 85% 3.

Carbon Dioxide Capture And Methane Storage

Bio-based MOFs with amine-functionalized linkers exhibit enhanced CO₂ adsorption capacity 214. A Zn-adenine MOF modified with ethylenediamine (–NH₂ loading: 3.